Enzolifesciences/nNOS polyclonal antibody/BML-SA227-0025/25µg

作者: 时间:2026-03-01 点击量:

Product Specification:

Alternative Name:Nitric oxide synthase (neuronal), NOS I
Host:Rabbit
Immunogen:Synthetic peptide corresponding to aa 1414-1434 (CRSESIAFIEESKKDTDEVFSS) of human brain NOS (nNOS; NOS1).
UniProt ID:P29475
Species reactivity:Human, Mouse, RatChicken
Applications:ELISA, ICC, IF, WB
Recommended Dilutions/Conditions:Western Blot (1-5 µg/ml)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application.
Purity Detail:Protein A-affinity purified.
Formulation:Liquid. In PBS containing 0.05% sodium azide.
Handling:Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Scientific Background:The diffusible free radical gas nitric oxide (NO) affects a variety of physiological functions, and is a key regulator of the cardiovascular, nervous, and immune systems. NO is synthesized in many tissues from L-arginine, oxygen, and NADPH by three known isoforms of a heme-containing flavoprotein termed NO synthase (nNOS/NOS-I, iNOS/NOS-II, and eNOS/NOS-III). nNOS is a constitutively expressed neuronal NOS isoform that exits in its latent form until it is activated by the binding of calmodulin follo wing elevation of intracellular calcium levels. The C-terminus of nNOS contains a conserved serine residue, Ser1417, analogous to Ser1177 of the constitutively expressed endothelial NOS isoform (eNOS). Phosphorylation of Ser1417 is believed to regulate nNOS activation, particularly in glucose-sensing neurons, where inhibition of AMPK pathways by glucose and leptin serve to suppress nNOS activity, whereas activation of AMPK by insulin leads to nNOS activation.

>>> 更多资讯详情请访问蚂蚁淘商城